CCL2 at the crossroad of cancer metastasis

References

• Rampetsreiter P, Casanova E, Eferl R. Genetically modified mouse models of cancer invasion and metastasis. Drug Discov Today Dis Models 2011; 8:67 - 74; http://dx.doi.org/10.1016/j.ddmod.2011.05.003; PMID: 22577462
   PubMedGoogle Scholar
• Spano D, Heck C, De Antonellis P, Christofori G, Zollo M. Molecular networks that regulate cancer metastasis. Semin Cancer Biol 2012; 22:234 - 49; http://dx.doi.org/10.1016/j.semcancer.2012.03.006; PMID: 22484561
   PubMed Web of Science ®Google Scholar
• Huh SJ, Liang S, Sharma A, Dong C, Robertson GP. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 2010; 70:6071 - 82; http://dx.doi.org/10.1158/0008-5472.CAN-09-4442; PMID: 20610626
   PubMed Web of Science ®Google Scholar
• Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011; 20:576 - 90; http://dx.doi.org/10.1016/j.ccr.2011.09.009; PMID: 22094253
   PubMed Web of Science ®Google Scholar
• Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002; 20:4368 - 80; http://dx.doi.org/10.1200/JCO.2002.10.088; PMID: 12409337
   PubMed Web of Science ®Google Scholar
• Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012; 22:146 - 57; http://dx.doi.org/10.1016/j.devcel.2011.11.002; PMID: 22264731
   PubMed Web of Science ®Google Scholar
• Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, et al. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 2008; 22:308 - 21; http://dx.doi.org/10.1101/gad.1632008; PMID: 18245446
   PubMed Web of Science ®Google Scholar
• Gavard J, Gutkind JS. Protein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha12/13 and Galpha11/q. J Biol Chem 2008; 283:29888 - 96; http://dx.doi.org/10.1074/jbc.M803880200; PMID: 18713748
   PubMed Web of Science ®Google Scholar
• Wolf MJ, Hoos A, Bauer J, Boettcher S, Knust M, Weber A, et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 2012; 22:91 - 105; http://dx.doi.org/10.1016/j.ccr.2012.05.023; PMID: 22789541
   PubMed Web of Science ®Google Scholar
• Mukaida N, Baba T. Chemokines in tumor development and progression. Exp Cell Res 2012; 318:95 - 102; http://dx.doi.org/10.1016/j.yexcr.2011.10.012; PMID: 22036649
   PubMed Web of Science ®Google Scholar
• Huang B, Lei Z, Zhao J, Gong W, Liu J, Chen Z, et al. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett 2007; 252:86 - 92; http://dx.doi.org/10.1016/j.canlet.2006.12.012; PMID: 17257744
   PubMed Web of Science ®Google Scholar
• Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011; 475:222 - 5; http://dx.doi.org/10.1038/nature10138; PMID: 21654748
   PubMed Web of Science ®Google Scholar
• Gálvez BG, Genís L, Matías-Román S, Oblander SA, Tryggvason K, Apte SS, et al. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis. J Biol Chem 2005; 280:1292 - 8; http://dx.doi.org/10.1074/jbc.M408673200; PMID: 15516694
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Amano S, Furuya M, Namiki K, Sakurai K, Nishiyama M, et al. Involvement of p38alpha mitogen-activated protein kinase in lung metastasis of tumor cells. J Biol Chem 2006; 281:36767 - 75; http://dx.doi.org/10.1074/jbc.M604371200; PMID: 17028194
   PubMed Web of Science ®Google Scholar
• Ho MK, Su Y, Yeung WW, Wong YH. Regulation of transcription factors by heterotrimeric G proteins. Curr Mol Pharmacol 2009; 2:19 - 31; PMID: 20021442
   PubMedGoogle Scholar
• Shi Z, Hodges VM, Dunlop EA, Percy MJ, Maxwell AP, El-Tanani M, et al. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Mol Cancer Res 2010; 8:615 - 26; http://dx.doi.org/10.1158/1541-7786.MCR-09-0264; PMID: 20353997
   PubMed Web of Science ®Google Scholar
• Wang S, Koromilas AE. Stat1 is an inhibitor of Ras-MAPK signaling and Rho small GTPase expression with implications in the transcriptional signature of Ras transformed cells. Cell Cycle 2009; 8:2070 - 9; http://dx.doi.org/10.4161/cc.8.13.8891; PMID: 19502801
   PubMed Web of Science ®Google Scholar
• Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci 2004; 117:1281 - 3; http://dx.doi.org/10.1242/jcs.00963; PMID: 15020666
   PubMed Web of Science ®Google Scholar
• Lu X, Kang Y. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem 2009; 284:29087 - 96; http://dx.doi.org/10.1074/jbc.M109.035899; PMID: 19720836
   PubMed Web of Science ®Google Scholar
• Loberg RD, Ying C, Craig M, Yan L, Snyder LA, Pienta KJ. CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia 2007; 9:556 - 62; http://dx.doi.org/10.1593/neo.07307; PMID: 17710158
   PubMed Web of Science ®Google Scholar
• Loberg RD, Ying C, Craig M, Day LL, Sargent E, Neeley C, et al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 2007; 67:9417 - 24; http://dx.doi.org/10.1158/0008-5472.CAN-07-1286; PMID: 17909051
   PubMed Web of Science ®Google Scholar
• Zollo M, Di Dato V, Spano D, De Martino D, Liguori L, Marino N, et al. Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. Clin Exp Metastasis 2012; 29:585 - 601; http://dx.doi.org/10.1007/s10585-012-9473-5; PMID: 22484917
   PubMed Web of Science ®Google Scholar
• Han N, Jin K, He K, Cao J, Teng L. Protease-activated receptors in cancer: A systematic review. Oncol Lett 2011; 2:599 - 608; PMID: 22848234
   PubMed Web of Science ®Google Scholar
• Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006; 8:1223 - 34; http://dx.doi.org/10.1038/ncb1486; PMID: 17060906
   PubMed Web of Science ®Google Scholar